FDA Approved: AMMONIA N 13 — Supplemental Application (3D Imaging Drug Design and Development LLC)

View source ↗

Summary

FDA approved a supplemental application for AMMONIA N 13, a PET imaging radiopharmaceutical, submitted by 3D Imaging Drug Design and Development LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Ischemic Heart Disease

Drugs mentioned

• AMMONIA N 13 (NH3N13)

Snippet

SUPPL AP for AMMONIA N 13 (AMMONIA N-13)